New Edge Advisors, LLC Adma Biologics, Inc. Transaction History
New Edge Advisors, LLC
- $18.3 Billion
- Q2 2025
A detailed history of New Edge Advisors, LLC transactions in Adma Biologics, Inc. stock. As of the latest transaction made, New Edge Advisors, LLC holds 28,913 shares of ADMA stock, worth $420,395. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,913
Previous 234
12255.98%
Holding current value
$420,395
Previous $4,000
13050.0%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ADMA
# of Institutions
400Shares Held
196MCall Options Held
2.08MPut Options Held
1.56M-
Vanguard Group Inc Valley Forge, PA21.4MShares$311 Million0.01% of portfolio
-
Black Rock Inc. New York, NY18.6MShares$271 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA12.8MShares$186 Million0.04% of portfolio
-
State Street Corp Boston, MA12.1MShares$176 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.91MShares$86 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $2.86B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...